Skip to main content
Premium Trial:

Request an Annual Quote

David Feny, Michael Washburn, John Yates, Tim Sutton, David Campbell, RJ Twilegar, Tim Burland

Premium

David Fenyö has become a staff scientist at Amersham Biosciences, joining the company in January. Prior to that, he was director of proteomics at Ann Arbor, Mich.-based Genomic Solutions. He joined Genomic Solutions in 2002 after it acquired the technology of ProteoMetrics of New York, which Fenyö co-founded and where he served as president. He holds a PhD in physics from Uppsala University in Sweden.

Michael Washburn has been appointed as director of proteomics at the Kansas City, Mo.-based Stowers Institute for Medical Research. He will join the institute later this year from the Torrey Mesa Research Institute in San Diego, where he is a senior staff scientist in proteomics. He holds a BA in chemistry from Grinnell College and a PhD in biochemistry and environmental toxicology from Michigan State University and did a postdoc with John Yates at the University of Washington.

Tim Sutton has become CFO of Huntingdon, UK-based NextGen Sciences as well as a member of the company’s board of directors. Previously, he worked with companies that include T-Mobile UK, Adaptive Broadband, and Quante.

David Campbell has been promoted to the newly-created position of senior vice president for chemical sciences at ActivX Biosciences. Prior to joining the La Jolla, Calif.-based company in 2001, he was director of discovery chemistry at Bayer. Before that, he held various positions at Affymax Research Institute. Campbell holds a BS in chemistry from Harvey Mudd College and a PhD in organic chemistry from Cornell University.

RJ Twilegar has become CEO of Madison, Wis.-based GWC Instruments. He was a professor of entrepreneurship at the Universidad San Francisco de Quito in Ecuador. Twilegar holds a JD from George Washington University School.

GWC also appointed Tim Burland as vice president for technology development. Most recently he was general manager of DNASTAR. He holds a PhD in genetics from the University of Leicester in the UK.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.